Loading clinical trials...
Loading clinical trials...
A Phase 1, Safety, Tolerability, Single-ascending Dose, Multiple-ascending Dose, Food Effect, and Pharmacokinetic Study of TML-6 in Healthy Volunteers
Conditions
Interventions
TML-6 Granules
Placebo
Locations
1
United States
Parexel International
Glendale, California, United States
Start Date
July 11, 2024
Primary Completion Date
July 18, 2025
Completion Date
August 15, 2025
Last Updated
October 30, 2025
NCT06716502
NCT00090662
NCT06290258
NCT07310264
NCT07483606
NCT06342713
Lead Sponsor
Merry Life Biomedical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions